
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Lead poisoning: The correct therapy, possible sources / Two views on exaggerated inspirations / Virginity pledges: Some value after all / Keep euphemisms out of the medical office






